Trial Profile
Double-blind, single-dose escalation study of PTC-299 in Healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Aug 2016
Price :
$35
*
At a glance
- Drugs Emvododstat (Primary)
- Indications Breast cancer; CNS cancer; Neurofibromatoses; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors PTC Therapeutics
- 01 Jul 2016 Results published in the Clinical Pharmacology in Drug Development
- 04 Dec 2006 Checked against 1054820.
- 21 Jun 2006 New trial record.